Skip to content

A Single-Ascending-Dose Study of MK6916 in Healthy Participants

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-510971-39-00
Acronym
MK-6916-001
Enrollment
16
Registered
2024-04-25
Start date
2024-05-03
Completion date
2024-09-25
Last updated
2024-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute and chronic Pain

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026